Healthequity Stock Earnings Reports

HealthEquity reported a strong Q2 fiscal 2026 with broad growth, margin expansion, and heightened operational efficiency. Key financials: revenue +9% YoY, net income +67% YoY, adjusted EBITDA +18% to a company quarterly high, record gross margin of 71%, HSA assets +12% to >$33B, ~17M total accounts, ~10M HSAs, invested HSA assets +23% to $16.1B. Management raised FY26 guidance (revenue $1.29–1.31B; GAAP net income $185–200M; non‑GAAP net income $329–344M; adjusted EBITDA $540–560M). Strategic and operational highlights: major legislative wins expanding HSA eligibility (notably bronze and catastrophic ACA plans effective 1/1/2026, plus allowance for DPC and low‑cost telehealth), ongoing marketing and enrollment redesign to capture the newly eligible market, completion of v5 platform migration to cloud (faster response, improved stability), AI deployments (expedited claims, agentic/voice) to improve service and reduce costs, improved fraud controls including passkey rollout and reduced fraud costs (target: ~1 bps of HSA assets annually), $200M cash from operations YTD, ~$1B net debt, $66M share repurchases in the quarter and $352M remaining authorization, and $1.2B of treasury forward contracts to derisk HSA cash yields. Management expects to reinvest cash flow into technology, security, sales/marketing for the ACA opportunity, debt paydown, and further buybacks, while retaining capacity for acquisitions.